Switch theme
Sign up to access all valuation multiples
Middle East Healthcare Co is a Saudi Arabia-based company engaged in the business of managing, operating and maintaining hospitals, medical centers, educational centers, rehabilitation centers, physiotherapy, laboratories and radiology centers, pharmacies, construction, and to buy land for the purpose of constructing medical projects and to establish, manage and organize exhibitions for the company.
2004
n/a
LTM Revenue $805M
LTM EBITDA $182M
$2.0B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Middle East Healthcare has a last 12-month revenue (LTM) of $805M and a last 12-month EBITDA of $182M.
In the most recent fiscal year, Middle East Healthcare achieved revenue of $769M and an EBITDA of $200M.
Middle East Healthcare expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Middle East Healthcare valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $805M | XXX | $769M | XXX | XXX | XXX |
| Gross Profit | $311M | XXX | $297M | XXX | XXX | XXX |
| Gross Margin | 39% | XXX | 39% | XXX | XXX | XXX |
| EBITDA | $182M | XXX | $200M | XXX | XXX | XXX |
| EBITDA Margin | 23% | XXX | 26% | XXX | XXX | XXX |
| EBIT | $123M | XXX | $119M | XXX | XXX | XXX |
| EBIT Margin | 15% | XXX | 15% | XXX | XXX | XXX |
| Net Profit | $77.4M | XXX | $75.3M | XXX | XXX | XXX |
| Net Margin | 10% | XXX | 10% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $622M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Middle East Healthcare's stock price is SAR 60 (or $16).
Middle East Healthcare has current market cap of SAR 5.6B (or $1.5B), and EV of SAR 7.7B (or $2.0B).
See Middle East Healthcare trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.0B | $1.5B | XXX | XXX | XXX | XXX | $0.81 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Middle East Healthcare has market cap of $1.5B and EV of $2.0B.
Middle East Healthcare's trades at 2.7x EV/Revenue multiple, and 10.3x EV/EBITDA.
Equity research analysts estimate Middle East Healthcare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Middle East Healthcare has a P/E ratio of 19.2x.
See valuation multiples for Middle East Healthcare and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.5B | XXX | $1.5B | XXX | XXX | XXX |
| EV (current) | $2.0B | XXX | $2.0B | XXX | XXX | XXX |
| EV/Revenue | 2.5x | XXX | 2.7x | XXX | XXX | XXX |
| EV/EBITDA | 11.2x | XXX | 10.3x | XXX | XXX | XXX |
| EV/EBIT | 16.6x | XXX | 17.2x | XXX | XXX | XXX |
| EV/Gross Profit | 6.6x | XXX | n/a | XXX | XXX | XXX |
| P/E | 19.2x | XXX | 19.7x | XXX | XXX | XXX |
| EV/FCF | 29.5x | XXX | 26.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialMiddle East Healthcare's last 12 month revenue growth is 11%
Middle East Healthcare's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
Middle East Healthcare's rule of 40 is 32% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Middle East Healthcare's rule of X is 51% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Middle East Healthcare and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 11% | XXX | 11% | XXX | XXX | XXX |
| EBITDA Margin | 23% | XXX | 26% | XXX | XXX | XXX |
| EBITDA Growth | 8% | XXX | 15% | XXX | XXX | XXX |
| Rule of 40 | 32% | XXX | 37% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 51% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 3% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 23% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Middle East Healthcare acquired XXX companies to date.
Last acquisition by Middle East Healthcare was XXXXXXXX, XXXXX XXXXX XXXXXX . Middle East Healthcare acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Middle East Healthcare founded? | Middle East Healthcare was founded in 2004. |
| Where is Middle East Healthcare headquartered? | Middle East Healthcare is headquartered in Saudi Arabia. |
| Is Middle East Healthcare publicy listed? | Yes, Middle East Healthcare is a public company listed on SAU. |
| What is the stock symbol of Middle East Healthcare? | Middle East Healthcare trades under 4009 ticker. |
| When did Middle East Healthcare go public? | Middle East Healthcare went public in 2016. |
| Who are competitors of Middle East Healthcare? | Similar companies to Middle East Healthcare include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Middle East Healthcare? | Middle East Healthcare's current market cap is $1.5B |
| What is the current revenue of Middle East Healthcare? | Middle East Healthcare's last 12 months revenue is $805M. |
| What is the current revenue growth of Middle East Healthcare? | Middle East Healthcare revenue growth (NTM/LTM) is 11%. |
| What is the current EV/Revenue multiple of Middle East Healthcare? | Current revenue multiple of Middle East Healthcare is 2.5x. |
| Is Middle East Healthcare profitable? | Yes, Middle East Healthcare is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Middle East Healthcare? | Middle East Healthcare's last 12 months EBITDA is $182M. |
| What is Middle East Healthcare's EBITDA margin? | Middle East Healthcare's last 12 months EBITDA margin is 23%. |
| What is the current EV/EBITDA multiple of Middle East Healthcare? | Current EBITDA multiple of Middle East Healthcare is 11.2x. |
| What is the current FCF of Middle East Healthcare? | Middle East Healthcare's last 12 months FCF is $69.4M. |
| What is Middle East Healthcare's FCF margin? | Middle East Healthcare's last 12 months FCF margin is 9%. |
| What is the current EV/FCF multiple of Middle East Healthcare? | Current FCF multiple of Middle East Healthcare is 29.5x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
